We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $350M
1-Year Est. Return 33.5%
This Fund
S&P 500
This Quarter Est. Return
+13.09%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$323M
AUM Growth
+$14.5M
Cap. Flow
-$9.38M
Cap. Flow %
-2.91%
Top 10 Hldgs %
64.81%
Holding
40
New
Increased
2
Reduced
5
Closed
1

Top Buys

Rank Stock Value
1
LYB icon
LyondellBasell Industries
LYB
+$1.13M
2
FATE icon
Fate Therapeutics
FATE
+$323K

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$4.26M
2
CMS icon
CMS Energy
CMS
+$2.87M
3
DUK icon
Duke Energy
DUK
+$2.43M
4
LVTX
LAVA Therapeutics
LVTX
+$689K
5
KOD icon
Kodiak Sciences
KOD
+$377K

Sector Composition

Rank Sector Weight
1 Healthcare 27.27%
2 Utilities 24.23%
3 Industrials 19.38%
4 Financials 9.17%
5 Consumer Staples 5.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLI icon
26
RLI Corp
RLI
$5.66B
$2.66M 0.82%
40,800
PSNL icon
27
Personalis
PSNL
$1.61B
$1.65M 0.51%
253,000
LLY icon
28
Eli Lilly
LLY
$1.05T
$1.53M 0.47%
2,000
VG
29
Venture Global Inc
VG
$34.3B
$1.42M 0.44%
100,000
SIRI icon
30
SiriusXM
SIRI
$10.3B
$1.3M 0.4%
55,784
BHC icon
31
Bausch Health
BHC
$1.8B
$1.1M 0.34%
171,000
MNKD icon
32
MannKind Corp
MNKD
$1.25B
$1.05M 0.32%
195,073
FOCL
33
EDAP TMS S.A.
FOCL
$204M
$1.01M 0.31%
438,652
-115,000
-21% -$208K
FATE icon
34
Fate Therapeutics
FATE
$324M
$919K 0.28%
729,188
+300,000
+70% +$323K
ASH icon
35
Ashland
ASH
$3.14B
$719K 0.22%
15,000
MASS icon
36
908 Devices
MASS
$302M
$598K 0.19%
68,286
CRBU icon
37
Caribou Biosciences
CRBU
$164M
$583K 0.18%
250,000
VTRS icon
38
Viatris
VTRS
$20.1B
$577K 0.18%
58,279
WEC icon
39
WEC Energy
WEC
$36.9B
$452K 0.14%
3,945
LVTX
40
DELISTED
LAVA Therapeutics
LVTX
-521,874
Closed -$689K

Similar funds

Bruce & Co's Q3 2025 Portfolio in Review

As of Q3 2025, Bruce & Co held 40 positions worth $323M, up 4.7% from $308M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Trading was light in Q3 2025: portfolio turnover was 2.5%. Bruce & Co opened no new positions and exited 1, leaving the 40-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Utilities and Industrials.

  • Bruce & Co added most to LyondellBasell Industries in Q3 2025, an estimated $1.13M increase.
  • Bruce & Co's biggest Q3 2025 reduction was AT&T, cutting an estimated $4.26M.
  • Bruce & Co fully exited LAVA Therapeutics in Q3 2025, selling an estimated $689K.
  • Bruce & Co's ten largest holdings make up 65% of its $323M portfolio in Q3 2025.
  • Bruce & Co opened 0 new positions and closed 1 in Q3 2025.
  • Bruce & Co's portfolio value rose 4.7% quarter-over-quarter to $323M.

Based on Bruce & Co's 13F filing for Q3 2025, filed 13 Nov 2025.